Skip to main content

Table 3 Validation and Regression parameters of the proposed HPLC–DAD and LC–MS/MS methods

From: Sustainable chromatographic quantitation of multi-antihypertensive medications: application on diverse combinations containing hydrochlorothiazide along with LC–MS/MS profiling of potential impurities: greenness and whiteness evaluation

Method Parameter

HPLC–DAD method

LC–MS/MS method

HCT

CT

DSA

VAL

AML

ATN

AMI

CAN

CT

SAL

Linearity rangea

0.10–100.00

0.05–8.00

0.10–100.0

0.05–100.00

0.10–100.00

1.0–200.0

5.0–200.0

Regression equation parameters

 Slope

0.0530

0.4789

0.4957

0.0449

0.0493

0.0492

0.4940

0.0502

92.062

1.4412

 Intercept

0.0051

0.0343

0.0134

0.0889

0.0169

0.0084

0.0155

0.0020

29.337

0.8209

 Correlation Coefficient (r)

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

0.9999

0.9999

 Accuracy b (Mean ± SD)

99.51 ± 0.68

100.44 ± 0.59

100.52 ± 0.69

100.18 ± 0.86

100.57 ± 1.05

99.25 ± 0.77

99.97 ± 0.69

99.03 ± 0.75

99.92 ± 0.60

99.64 ± 0.77

Precision (± %RSD)

 Repeatability c

0.85

0.38

0.69

0.75

0.48

0.37

0.25

0.55

0.88

0.61

 Intermediate precision d

0.91

0.80

0.86

0.87

0.53

0.48

0.48

0.76

1.00

0.78

 LOD e

0.01

0.01

0.01

0.02

0.01

0.01

0.01

0.03

0.19

0.14

 LOQ e

0.05

0.02

0.02

0.06

0.02

0.03

0.03

0.08

0.59

0.41

 Robustness f

0.96

0.79

0.88

0.79

0.88

1.15

0.85

0.98

0.65

0.52

  1. a For HPLC–DAD method: in μg/mL and for LC–MS/MS method: in ng/mL
  2. b Accuracy was checked using concentrations for HPLC–DAD method: 0.2, 40.0 and 80.0 µg/mL for HCT, VAL, AML, ATN, AMI and CAN and 0.3, 3.0 and 7.0 µg/mL for CT and SAL while for LC–MS/MS method: 40.0, 80.0 and 120.0 ng/mL for CT and SAL
  3. c and d are repeatability and intermediate precision, respectively (n = 9) percentage relative standard deviation of three different concentrations in triplicate for HPLC–DAD method: 0.5, 20.0 and 60.0 µg/mL for HCT, VAL, AML, ATN, AMI and CAN and 0.1, 2.0 and 5.0 µg/mL for CT and SAL while for LC–MS/MS method: 5.0, 50.0 and 150.0 ng/mLfor CT and 10.0, 50.0 and 150.0 ng/mL for SAL
  4. e LOD and LOQ were calculated as per ICH, 3.3 × SD of the intercept/slope and 10 × SD of the intercept/slope, respectively
  5. f For HPLC–DAD: average %RSD of the change in detection wavelength (± 1 nm) and flow rate (± 0.1 mL/min), while for LC–MS/MS: average %RSD of the change in the mobile phase composition (± 2%)